Orexigen Therapeutics (OREX) Reports Q2 Loss of $2.00/Share
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Total other income (expense): 5.14M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total other income (expense): 5.14M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q2 EPS of ($2.00), versus ($1.73) reported last year. Revenue for the quarter came in at $23.4 million versus the consensus estimate of $19.14 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
